Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-01

The health insurers (whether HEK and/or hkk participate in the respective lot is derived from the designation of the respective lot) aim to conclude discount contracts under § 130a para. 8 SGB V with all suitable pharmaceutical companies for the active substances, active substance combinations, dosage forms, strengths or finished medicinal products named in the respective lot. The medicinal products subject to the contract are - unless the contract provides otherwise - always all interchangeable finished medicinal products of the contracting partner according to the framework agreement on the supply of medicines under § 129 para. 2 SGB V. The contract is concluded within the framework of the open-house procedure: Individual negotiations on contract contents are not conducted, uniform conditions apply. The health insurers do not guarantee any exclusivity to individual contracting partners. The contract period is a maximum of 24 months, starting at the earliest on 01.03.2025 (possibly deviating start dates result from the information for the corresponding lot). The contract ends at the latest on 28.02.2027 (possible exceptions result from the information for the corresponding lot), regardless of the date of contract conclusion. Joining this open-house procedure is possible at any time during the contract period. All further information can be found in the participation and contract documents.